The Patent Finder
US

Gene Therapies for Lysosomal Disorders

US 12,571,002 In force
OverviewFamilyAssignmentsSources & methods

Term ends Oct 3, 2038 · High confidence

Filed Jul 7, 2021 as application 17/369,168 · Granted Mar 10, 2026
Base term plus 1281 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2018 2038
Clock starts
Oct 3, 2018
Term ends
Oct 3, 2038
Granted
Mar 10, 2026
base term Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,281
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,837,028, US 11,060,113, US 11,802,294, US 11,903,985.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 1281 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 3, 2018, when application PCT/US2018/054225, the earliest non-provisional in its chain, was filed (this one was filed Jul 7, 2021)Oct 3, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1281 days, USPTO patent term adjustment recordApr 6, 2042High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,837,028, US 11,060,113, US 11,802,294, US 11,903,985)capped to Oct 3, 2038High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 3, 2038High confidence

This family

Application PCT/US2018/054225PCT application
no patent term
no patent term
US 10,837,028In force
Oct 2038
Oct 2038
US 11,802,294In force
Aug 2040
Aug 2040
US 11,060,113In force
Oct 2038
Oct 2038
US 12,571,002this patent
Oct 2038
Oct 2038
Application 19/465,370Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 1, 2021
Reel 57669, frame 401
Abeliovich, Asa; Heckman, Laura; Rhinn, HervePrevail Therapeutics, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited